JPWO2021074649A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021074649A5 JPWO2021074649A5 JP2022523126A JP2022523126A JPWO2021074649A5 JP WO2021074649 A5 JPWO2021074649 A5 JP WO2021074649A5 JP 2022523126 A JP2022523126 A JP 2022523126A JP 2022523126 A JP2022523126 A JP 2022523126A JP WO2021074649 A5 JPWO2021074649 A5 JP WO2021074649A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- subject
- probiotic
- probiotic preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1915144.8 | 2019-10-18 | ||
| GB201915144A GB201915144D0 (en) | 2019-10-18 | 2019-10-18 | Method of promoting SCFA production by gut microbiota |
| PCT/GB2020/052621 WO2021074649A2 (en) | 2019-10-18 | 2020-10-16 | Methods of promoting scfa production by gut microbiota |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022553017A JP2022553017A (ja) | 2022-12-21 |
| JPWO2021074649A5 true JPWO2021074649A5 (de) | 2023-10-20 |
Family
ID=68728134
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523126A Pending JP2022553017A (ja) | 2019-10-18 | 2020-10-16 | 腸内微生物叢によりｓｃｆａ産生を促進する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20230053778A1 (de) |
| EP (1) | EP4044830A2 (de) |
| JP (1) | JP2022553017A (de) |
| CN (2) | CN114745970B (de) |
| AU (1) | AU2020368684A1 (de) |
| BR (1) | BR112022007413A2 (de) |
| CA (1) | CA3154083A1 (de) |
| DE (1) | DE20796905T1 (de) |
| ES (1) | ES2922359T1 (de) |
| GB (1) | GB201915144D0 (de) |
| MX (1) | MX2022004382A (de) |
| WO (1) | WO2021074649A2 (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| CN113875975B (zh) * | 2021-09-03 | 2023-06-30 | 许昌学院 | 一种利用小麦加工副产物制备后生元的发酵工艺 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6899872B1 (en) * | 1995-11-27 | 2005-05-31 | Standa Lab Sa | Absorbable dietary composition for improving the biological balance of intestinal tract flora |
| GB2418431A (en) * | 2004-09-27 | 2006-03-29 | Multigerm Uk Entpr Ltd | Metabolically active micro organisms and methods for their production |
| JP6006117B2 (ja) * | 2009-11-12 | 2016-10-12 | ネステク ソシエテ アノニム | 腸内微生物叢バランス及び健康を促進するための栄養組成物 |
| US8585588B2 (en) * | 2009-11-18 | 2013-11-19 | Nohands, Llc | Method and system for preventing virus-related obesity and obesity related diseases |
| US9707207B2 (en) * | 2010-05-26 | 2017-07-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for diagnosing, preventing, and treating neurological diseases |
| US10512661B2 (en) * | 2011-02-04 | 2019-12-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| US10548761B2 (en) * | 2011-02-04 | 2020-02-04 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| US10842834B2 (en) * | 2016-01-06 | 2020-11-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
| US10086018B2 (en) * | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
| GB201219873D0 (en) * | 2012-11-05 | 2012-12-19 | Multigerm Uk Entpr Ltd | Diverticulitis treatment |
| US8889633B2 (en) * | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
| WO2015159125A1 (en) * | 2014-04-15 | 2015-10-22 | Compagnie Gervais Danone | Use of lactobacillus rhamnosus for promoting recovery of the intestinal microbiota diversity after antibiotic dysbiosis |
| EP4257194A3 (de) * | 2016-02-04 | 2023-12-20 | Universiteit Gent | Verwendung von mikrobiellen gemeinschaften für human- und tiergesundheit |
| US10055534B2 (en) * | 2016-03-17 | 2018-08-21 | Applied Materials Israel Ltd. | System and method for design based inspection |
| KR20180133443A (ko) * | 2016-04-11 | 2018-12-14 | 바게닝겐 유니버시테이트 | 신규한 세균 종 |
| US20180357375A1 (en) * | 2017-04-04 | 2018-12-13 | Whole Biome Inc. | Methods and compositions for determining metabolic maps |
| US11730749B2 (en) * | 2017-05-05 | 2023-08-22 | Plexus Worldwide, Llc | Compositions and methods for improving gut health |
| AU2018313765A1 (en) * | 2017-08-07 | 2020-02-27 | Finch Therapeutics, Inc. | Compositions and methods for decolonizing antibotic-resistant bacteria in the gut |
| US11602552B2 (en) * | 2018-02-02 | 2023-03-14 | Kobiolabs, Inc. | Lactobacillus plantarum KBL396 strain and use thereof |
| GB201915144D0 (en) * | 2019-10-18 | 2019-12-04 | Multigerm Uk Entpr Ltd | Method of promoting SCFA production by gut microbiota |
| EP4376853A2 (de) * | 2021-08-01 | 2024-06-05 | SNIPR Biome ApS. | Mikrobiota-engineering |
-
2019
- 2019-10-18 GB GB201915144A patent/GB201915144D0/en not_active Ceased
-
2020
- 2020-10-16 CA CA3154083A patent/CA3154083A1/en active Pending
- 2020-10-16 MX MX2022004382A patent/MX2022004382A/es unknown
- 2020-10-16 BR BR112022007413A patent/BR112022007413A2/pt unknown
- 2020-10-16 US US17/769,125 patent/US20230053778A1/en active Pending
- 2020-10-16 DE DE20796905.6T patent/DE20796905T1/de active Pending
- 2020-10-16 JP JP2022523126A patent/JP2022553017A/ja active Pending
- 2020-10-16 CN CN202080081506.3A patent/CN114745970B/zh active Active
- 2020-10-16 EP EP20796905.6A patent/EP4044830A2/de active Pending
- 2020-10-16 CN CN202410747338.7A patent/CN118593548A/zh active Pending
- 2020-10-16 ES ES20796905T patent/ES2922359T1/es active Pending
- 2020-10-16 AU AU2020368684A patent/AU2020368684A1/en active Pending
- 2020-10-16 WO PCT/GB2020/052621 patent/WO2021074649A2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110167637B (zh) | 3-羟基丁酸甘油酯用于偏头痛症状管理 | |
| Kim et al. | Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice | |
| CN108289918B (zh) | 经巴氏灭菌的艾克曼菌用于治疗代谢病症的用途 | |
| JP2020504134A5 (de) | ||
| JP2012126736A5 (de) | ||
| US10137108B2 (en) | Nutritional composition useful in the treatment of IBD patients | |
| ES2924041T3 (es) | Materia fecal para la prevención o el tratamiento de enfermedades autoinmunes | |
| US9901610B2 (en) | Formulations for the treatment and prevention of obesity | |
| Lu et al. | Bacillus licheniformis Zhengchangsheng® Inhibits obesity by regulating the AMP-Activated protein kinase signaling pathway | |
| AU2012250877B2 (en) | Composition and method for treatment of diabetes | |
| JP2023520081A (ja) | 炎症性腸疾患に対する併用療法 | |
| JPWO2021074649A5 (de) | ||
| DE20796905T1 (de) | Verfahren zur förderung der scfa-produktion durch die darmflora | |
| Haskey et al. | Synbiotic therapy: a promising new adjunctive therapy for ulcerative colitis | |
| Radchenko et al. | Nonalcoholic steatohepatitis and biliary sludge in people with metabolic syndrome | |
| Rather et al. | Ulcerative colitis and probiotics: An overview. | |
| JP2024504555A (ja) | 急性膵炎を予防及び治療するための薬物の製造におけるノルハルマンの使用 | |
| Chibbar et al. | Treatment of inflammatory bowel disease in ulcerative colitis | |
| CN114585380A (zh) | 胃肠健康组合物 | |
| Danielewski et al. | Non-antibiotic use of antibiotics | |
| WO2005072718A1 (ja) | 乳清発酵物を含有する医薬組成物 | |
| JP4370054B2 (ja) | 腸粘膜傷害の予防及び治療剤 | |
| Castelnuovo et al. | Prebiotics targeting gut-liver axis to treat non-alcoholic fatty liver disease | |
| US20220387305A1 (en) | Composition and method for treatment of diabetes | |
| US20150224081A1 (en) | Composition and method for treatment of diabetes |